Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy.
Kenji MorimotoRyosuke HamashimaTadaaki YamadaToshihide YokoyamaTakehiko KobayashiKazunari TsuyuguchiTakanori KanematsuNobuyo TamiyaTaisuke TsujiRyota NakamuraYuki KatayamaNaoya NishiokaMasahiro IwasakuShinsaku TokudaKoichi TakayamaPublished in: Thoracic cancer (2024)
This study demonstrated that the cause of death in LC patients with concomitant CPA who received anticancer drug treatments and effective antifungal treatment was LC progression. Further large-scale studies are needed to identify the effect of CPA in patients with LC.